Influence of chalcone analogues on serum glucose levels in hyperglycemic rats

被引:38
作者
Alberton, Elga Heloisa [1 ]
Damazio, Rosangela Guollo [1 ]
Cazarolli, Luisa Helena [1 ]
Chiaradia, Louise Domeneghini [2 ]
Leal, Paulo Cesar [2 ]
Nunes, Ricardo Jose [2 ]
Yunes, Rosendo Augusto [2 ]
Mena Barreto Silva, Fatima Regina [1 ]
机构
[1] Univ Fed Santa Catarina, Dept Bioquim, Ctr Ciencias Biol, Campus Univ,Cx Postal 5069, BR-88040970 Florianopolis, SC, Brazil
[2] Univ Fed Santa Catarina, Dept Quim, Ctr Ciencias Fis & Matemat, BR-88040900 Florianopolis, SC, Brazil
关键词
chalcone; hyperglycemia; analogues; insulin; tolbutamide;
D O I
10.1016/j.cbi.2007.11.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
A series of chalcone derivatives from 3,4-methylenedioxybenzaldehyde and substituted acetophenones have been synthesized and investigated as antihyperglycemic agents in a glucose loaded animal model. Chalcones with biological activity were compared with lispro, regular insulin and tolbutamide effects on serum glucose levels. Compound 01, without substituent in the A-ring was not able to change glycemic levels. On the other hand, compounds 03, 04, 05, 09 and 10 with substitutions at position 3' and/or 4' in the A-ring caused significant reduction in serum glucose levels. Concerning the antihyperglycemic effect, compounds 03 and 05 (methoxy substituent) inhibited the hyperglycemia induced by glucose around 96% similar to that demonstrated for lispro insulin and tolbutamide at 60 min. A rapid and lasting antihyperglycemic effect was found with compound 09 and 10 (nitro substituent). In conclusion, besides the nature of the functional groups electron-donor substituent, as methoxy and hydroxyl or electron-acceptor, as nitro groups, the position of the group may be mandatory for biological activity. (c) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:355 / 362
页数:8
相关论文
共 34 条
[1]
Cardamonin, inhibits pro-inflammatory mediators in activated RAW 264.7 cells and whole blood [J].
Ahmad, Syahida ;
Israf, Daud A. ;
Lajis, Nordin Hj. ;
Shaari, Khozirah ;
Mohamed, Habsah ;
Wahab, Afiza A. ;
Ariffin, Khaizurin T. ;
Hoo, Wei Yee ;
Aziz, Nasaruddin A. ;
Kadir, Arifah A. ;
Sulaiman, Mohamad R. ;
Somchit, Muhammad N. .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 538 (1-3) :188-194
[2]
Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4
[3]
SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF 2'-HYDROXYCHALCONES AND FLAVONES AS INHIBITORS OF INFLAMMATORY MEDIATORS GENERATION [J].
BALLESTEROS, JF ;
SANZ, MJ ;
UBEDA, A ;
MIRANDA, MA ;
IBORRA, S ;
PAYA, M ;
ALCARAZ, MJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (14) :2794-2797
[4]
Banting FG, 1922, CAN MED ASSOC J, V7, P141
[5]
Follow-up studies on glycosylated flavonoids and their complexes with vanadium: Their anti-hyperglycemic potential role in diabetes [J].
Cazarolli, Luisa Helena ;
Zanatta, Leila ;
Jorge, Ana Paula ;
de Sousa, Eliandra ;
Horst, Heros ;
Woehl, Viviane Mara ;
Pizzolatti, Moacir Geraldo ;
Szpoganicz, Bruno ;
Mena Barreto Silva, Fatima Regina .
CHEMICO-BIOLOGICAL INTERACTIONS, 2006, 163 (03) :177-191
[6]
Natural PTP1B inhibitors from Broussonetia papyrifera [J].
Chen, RM ;
Hu, LH ;
An, TY ;
Li, J ;
Shen, Q .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (23) :3387-3390
[7]
Type 1 diabetes - Evidence for susceptibility loci from four genome-wide linkage scans in 1,435 multiplex families [J].
Concannon, P ;
Erlich, HA ;
Julier, C ;
Morahan, G ;
Nerup, J ;
Pociot, F ;
Todd, JA ;
Rich, SS .
DIABETES, 2005, 54 (10) :2995-3001
[8]
Hypoglycemic effect and antioxidant potential of kaempferol-3,7-O-(α)-dirhamnoside from Bauhinia forficata leaves [J].
de Sousa, E ;
Zanatta, L ;
Seifriz, I ;
Creezynski-Pasa, TB ;
Pizzolatti, MG ;
Szpoganiez, B ;
Silva, FRMB .
JOURNAL OF NATURAL PRODUCTS, 2004, 67 (05) :829-832
[9]
Synthesis of quinolinyl chalcones and evaluation of their antimalarial activity [J].
Domínguez, JN ;
Charris, JE ;
Lobo, G ;
de Domínguez, NG ;
Moreno, MM ;
Riggione, F ;
Sanchez, E ;
Olson, J ;
Rosenthal, PJ .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2001, 36 (06) :555-560
[10]
Novel insulins: Expanding options in diabetes management [J].
Gerich, JE .
AMERICAN JOURNAL OF MEDICINE, 2002, 113 (04) :308-316